Saito, Yuki
Okumura, Yasuo
Nagashima, Koichi
Fukamachi, Daisuke
Yokoyama, Katsuaki
Matsumoto, Naoya
Tachibana, Eizo
Kuronuma, Keiichiro
Oiwa, Koji
Matsumoto, Michiaki
Nishida, Toshihiko
Kojima, Toshiaki
Hanada, Shoji
Nomoto, Kazumiki
Sonoda, Kazumasa
Arima, Ken
Takahashi, Fumiyuki
Kotani, Tomobumi
Ohkubo, Kimie
Fukushima, Seiji
Itou, Satoru
Kondo, Kunio
Ando, Hideyuki
Ohno, Yasumi
Onikura, Motoyuki
Hirayama, Atsushi
Article History
Received: 12 February 2022
Accepted: 11 July 2022
First Online: 16 July 2022
Competing interests
: Dr. Okumura accepted remuneration and received research funding from Bayer Yakuhin Ltd, Daiichi-Sankyo, and Bristol-Meyers Squibb. Also, Dr. Okumura received scholarship funds from Daiichi-Sankyo, Boehringer Ingelheim, and Pfizer Japan. Dr. Hirayama accepted remuneration from Boehringer Ingelheim and Bristol-Meyers Squibb. None of the other authors have any conflicts of interest to declare.